Period of time： 2013年5期
Publisher： Future Medicine
Founded in： 2006
Total resources： 64
ISSN： 1746-0794
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Future Virology,volume 1,issue 5
Menu
The novel asymmetry of antibody binding
Future Virology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-09 , pp.
Access to resources
Recommend
Entecavir: a new treatment for chronic hepatitis B infection
By Schreibman Ian R,Schiff Eugene R in (2006)
Future Virology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-09 , pp.Where does adefovir stand amongst newly developed antivirals: from pharmacology to virology
Future Virology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-09 , pp.Combating viral resistance to treatment: VIRGIL after two successful years
Future Virology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-09 , pp.By Tomonaga Keizo,Ikuta Kazuyoshi in (2006)
Future Virology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-09 , pp.Antiviral drugs for influenza: Tamiflu® past, present and future
Future Virology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-09 , pp.How viruses shape the tree of life
By Villarreal Luis P in (2006)
Future Virology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-09 , pp.Genetic determinants of virulence in the group B coxsackieviruses
By Kim Kisoon,Kanno Toru,Chapman Nora M,Tracy Steven in (2006)
Future Virology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-09 , pp.Future of maraviroc and other CCR5 antagonists
By Overton E Turner,Powderly William G in (2006)
Future Virology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-09 , pp.Dendritic cell-mediated viral transmission: a potential drug target?
By de Witte Lot,van Kooyk Yvette,Geijtenbeek Teunis BH in (2006)
Future Virology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-09 , pp.
Previous
Next